Paula R. Pohlmann

Resistance to Trastuzumab in Breast Cancer

Paula R. Pohlmann, Ingrid A. Mayer, Ray Mernaugh · Clinical Cancer Research · 2009 · 507 citations · Full text

Medicine, Oncology, Pharmacology +15

TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases

Rachel A. Freedman, Rebecca Gelman, Carey K. Anders et al. · Journal of Clinical Oncology · 2019 · 338 citations · Full text

Medicine, Oncology, Pharmacology +17

Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies

Denise M. Wolf, Christina Yau, Julia Wulfkuhle et al. · Cancer Cell · 2022 · 326 citations · Full text

Medicine, Cancer Biology, Oncology +17

Atezolizumab Plus nab-Paclitaxel in the Treatment of Metastatic Triple-Negative Breast Cancer With 2-Year Survival Follow-up

Sylvia Adams, Jennifer R. Diamond, Erika Hamilton et al. · JAMA Oncology · 2018 · 283 citations · Full text

Medicine, Oncology, Pharmacology +17

Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer

Valerie M. Jansen, Neil E. Bhola, Joshua A. Bauer et al. · Cancer Research · 2017 · 250 citations

Medicine, Oncology, Pharmacology +17